Source: Health Canada shortage reports · Updated Oct 27, 2026
Some Milrinone products are in shortage in Canada (1 of 2 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
Products affected
1 / 2
Reports on file
15
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
MILRINONE LACTATE INJECTION, USP
1MG · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02244622 · since ?, no end estimate
Resolved
MILRINONE LACTATE INJECTION, USP
1MG · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02244622 · ended Apr 22, 2024 · Disruption of the manufacture of the drug.
Resolved
MILRINONE LACTATE INJECTION, USP
1MG · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02244622 · ended Mar 31, 2023
Resolved
MILRINONE LACTATE INJECTION, USP
1MG · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02244622 · ended Mar 31, 2023
Resolved
MILRINONE LACTATE INJECTION, USP
1MG · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02244622 · ended Nov 1, 2022
Resolved
MILRINONE LACTATE INJECTION, USP
1MG · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02244622 · ended Nov 1, 2022 · Disruption of the manufacture of the drug.
Resolved
MILRINONE LACTATE INJECTION, USP
1MG · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02244622 · ended Aug 24, 2022 · Disruption of the manufacture of the drug.
Resolved
MILRINONE LACTATE INJECTION, USP
1MG · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02244622 · ended Jul 31, 2022 · Disruption of the manufacture of the drug.
Resolved
MILRINONE LACTATE INJECTION, USP
1MG · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02244622 · ended Jul 31, 2022 · Delay in shipping of the drug.
Discontinued
MILRINONE LACTATE INJECTION
1MG · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02244854
Resolved
MILRINONE LACTATE INJECTION
1MG · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02244854 · ended Jun 17, 2022 · Disruption of the manufacture of the drug.
Resolved
MILRINONE LACTATE INJECTION, USP
1MG · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02244622 · ended Apr 30, 2022 · Demand increase for the drug.
Showing 12 of 15 reports. All reports are on file with Health Canada.
What's happening
Milrinone is currently affected by an active shortage report filed with Health Canada by FRESENIUS KABI CANADA LTD.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Milrinone is classified under “CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES” (ATC C01CE).
Recent changes
Oct 27, 2026
Status changed
Oct 16, 2026
New report filed
Common questions
When will Milrinone be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Milrinone in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.